HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cruickshank, A M Search for Related Content PubMed PubMed Citation Articles by Cruickshank, A M

ACP Best Practice No 166

CSF spectrophotometry in the diagnosis of subarachnoid haemorrhage

Department of Biochemistry, Southern General Hospital, Govan Road, Glasgow G51 4TF, UK

Dr Cruickshank anne.cruickshank{at}sgh.scot.nhs.uk After subarachnoid haemorrhage (SAH), cerebral angiography is usually performed to establish a site of bleeding, which may then be treated surgically to prevent a potentially catastrophic re-bleed. The investigation of choice in the diagnosis of SAH is computerised tomography (CT). However, because CT can miss some patients with SAH, cerebrospinal fluid (CSF) spectrophotometry should be performed in those patients with negative or equivocal CT scans or those who have presented several days after the suspected bleed. Spectrophotometry should aim to detect the presence of both oxyhaemoglobin and bilirubin because either one or both of these pigments may contribute to xanthochromia following SAH. CSF supernatant is scanned using a double beam spectrophotometer at wavelengths between 350 nm and 650 nm. Oxyhaemoglobin alone produces an absorption peak at 413–415 nm, bilirubin alone produces a broad peak at 450–460 nm, and bilirubin together with oxyhaemoglobin produce a shoulder at 450–460 nm on the downslope of the oxyhaemoglobin peak. To minimise the frequency of false positive and false negative results, a protocol has been developed, which is described.

Key Words: subarachnoid haemorrhage • computerised tomography • cerebrospinal fluid • spectrophotometry • oxyhaemoglobin • bilirubin • xanthochromia

This article has been cited by other articles:

				W A Liebenberg, R Worth, G B Firth, J Olney, and J S Norris Aneurysmal subarachnoid haemorrhage: guidance in making the correct diagnosis Postgrad. Med. J., July 1, 2005; 81(957): 470 - 473. [Abstract] [Full Text] [PDF]

				D. C. Heasley, M. A. Mohamed, and D. M. Yousem Clearing of Red Blood Cells in Lumbar Puncture Does Not Rule Out Ruptured Aneurysm in Patients with Suspected Subarachnoid Hemorrhage but Negative Head CT Findings AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 820 - 824. [Abstract] [Full Text] [PDF]

				L N Sandle The management of external quality assurance J. Clin. Pathol., February 1, 2005; 58(2): 141 - 144. [Full Text] [PDF]

				P J van Diest, H Holzel, M Reid, M Crook, and G Spickett Electronic publishing and internet learning J. Clin. Pathol., December 1, 2002; 55(12): 881 - 882. [Full Text] [PDF]

				S A Iversen CSF spectrophotometry in the diagnosis of subarachnoid haemorrhage J. Clin. Pathol., August 1, 2002; 55(8): 640 - 640. [Full Text] [PDF]

				R Beetham, M N Fahie-Wilson, I Holbrook, P Thomas, A M Ward, I D Watson, P R Wenham, P A E White, and A Cruickshank CSF spectrophotometry in the diagnosis of subarachnoid haemorrhage J. Clin. Pathol., June 1, 2002; 55(6): 479 - 480. [Full Text] [PDF]